Previous 10 | Next 10 |
Zynex continues to grow its top-line sequentially, set to post another record quarter in Q2. Despite this, investors have punished the stock in FY22, in search of idiosyncratic risk premia over beta-related return. In that vein, we find a lack of equity premia in ZYXI that investo...
Zynex, Inc. to Announce Second Quarter 2022 Financial Results PR Newswire ENGLEWOOD, Colo. , July 20, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medic...
Zynex ( NASDAQ: ZYXI ) reports that Q2 orders grew 19% Q/Q and 10% Y/Y, over Q2 2021, hitting the highest order total in Company history. Cash collections also remained strong during Q2. The company re-affirms Q2 revenue guidance of $35M-$38M ( $36.55M consensus ), up ...
Zynex Reports Preliminary Second Quarter 2022 Results and Reiterates Full Year Revenue and EBITDA Guidance PR Newswire ENGLEWOOD, Colo. , July 11, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in t...
Gainers: Ocean Bio-Chem OBCI +117%. Exela Technologies XELA +47%. Boxed BOXD +44%. Revlon REV +39%. Vivakor (VIVK) +22%. Omeros Corporation (OMER) +21%. Vor Biopharma (VOR) +21%. Wave Life Sciences WVE +18%. Siyata Mobile (SYTA) +18%. Visionary Education Technology (V...
Zynex Announces Change of Auditor PR Newswire ENGLEWOOD, Colo. , June 13, 2022 /PRNewswire/ -- Zynex, Inc . ("Zynex or the "Company) (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medi...
Two new Breakout Stocks for Week 24 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now up to +80.9% YTD. High frequency breakouts continue despite Negative Momentum Gauge® signals midweek with peak gains in 1 of 4 picks above 10%: L...
Zynex (ZYXI +0.8%) approved a program to buy back $10M of the company's common stock. The program will commence on June 10, 2022 and is scheduled to terminate on June 9, 2023 or when the $10M buyback limit is reached. Company expects to finance the purchases with existing cash balances, ...
Zynex Announces Additional Share Buyback Program PR Newswire ENGLEWOOD, Colo. , June 9, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...
The spread of the “recession” meme is starting to reach a fever pitch (1). In this case, it could counterintuitively be a positive catalyst for the long duration side of the market – ie, the long-term growth bets that are still in their early innings, with big fireworks s...
News, Short Squeeze, Breakout and More Instantly...
Zynex Sets Second Quarter 2024 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 17, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain manage...
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces PR Newswire ENGLEWOOD, Colo. , July 11, 2024 /PRNewswire/ -- Zy...